Free Trial

Sonoma Pharmaceuticals (SNOA) Earnings Date, Estimates & Call Transcripts

Sonoma Pharmaceuticals logo
$4.57 -0.25 (-5.19%)
Closing price 04:00 PM Eastern
Extended Trading
$4.66 +0.09 (+1.86%)
As of 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sonoma Pharmaceuticals Earnings Summary

Sonoma Pharmaceuticals released Q1 2026 earnings on August 7, 2025, reporting an EPS of -$0.37, which beat analysts' consensus estimates of -$0.51 by $0.14. Quarterly revenue was reported to be $4.01 million, below the consensus estimate of $4.26 million. With a trailing EPS of -$2.46, Sonoma Pharmaceuticals' earnings are expected to decrease next year, from ($0.67) to ($1.79) per share.

Q1 2026 Earnings Resources

SNOA Upcoming Earnings

Sonoma Pharmaceuticals' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules.

Upcoming Q2
Earnings Date
Nov. 6Before Market OpensEstimated
Consensus EPS
(Aug. 7)
-$0.51
Actual EPS
(Aug. 7)
-$0.37 Beat By $0.14
Actual Revenue
(Aug. 7)
$4.01M
Get Sonoma Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sonoma Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

SNOA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SNOA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sonoma Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.67) EPS
Next Year EPS Consensus Estimate
($1.79) EPS

Sonoma Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2025
(Estimated)
--------
8/7/2025Q1 2026-$0.51-$0.37+$0.14-$0.76$4.26M$4.01M
6/17/2025Q4 2025-$0.73-$0.15+$0.58-$0.48$4.44M$3.75M
2/5/2025Q3 2025--$0.59--$0.63--
11/7/2024---$0.59--$0.59-$3.58M
8/8/2024--$0.06-$0.07 -$0.01-$0.07-$3.39M
6/17/2024Q4 2024--$0.07--$0.07-$3.44M
2/8/2024Q4 2023-$0.21-$0.06+$0.15-$0.04-$3.14M
11/13/2023Q3 2023-$0.19-$0.20 -$0.01-$0.11-$2.73M

Sonoma Pharmaceuticals Earnings - Frequently Asked Questions

Sonoma Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on SNOA's earnings history.

In the previous quarter, Sonoma Pharmaceuticals (NASDAQ:SNOA) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.14. Learn more on analysts' earnings estimate vs. SNOA's actual earnings.

Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded annual revenue of $14.29 million.

Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded net income of -$3.46 million. SNOA has generated -$2.46 earnings per share over the last four quarters.

Sonoma Pharmaceuticals' earnings are expected to decrease from ($0.67) per share to ($1.79) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SNOA) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners